Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Newcells Biotech secures £1.2m for expanding customer base and seeking new partnerships

Dec 06, 2024•over 1 year ago

Contract Type

partnership

Newcastle DrawdockBiotechnologyMedicalPharmaceutical

Description

Newcells Biotech, a spin-out from the University of Newcastle, raises £1.2 million from existing investors to expand its customer base and seek new partnerships to enhance its product offerings. The funding brings the total amount raised by the company to over £13m, enabling faster drug development and reducing reliance on animal testing.

Company Information

Company

Newcells Biotech

Location

Newcastle Drawdock, England, United Kingdom

About

Newcells Biotech is a Newcastle, London, UK-based company specializing in 3D models that mimic processes within the body and are used by pharmaceutical companies worldwide to test the impact of their drugs, including their efficacy and safety. The company offers models of the retina, kidney, and lung, and provides specialist services to run customized tests.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Newcells Biotech's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.